Sort
34,240 grants matching “atherosclerosis”
Contributions of sleep to preclinical and clinical Alzheimer's disease
$846,851Jayandra Jung Himali · University Of Texas Hlth Science Center · R01 · FY2020 · AG
IOPSxV: Novel Visualization for Non-Fluoroscopic 3D Image Guidance for Peripheral Vascular Interventions.
$846,718Vikash Goel · Centerline Biomedical, Inc. · R44 · FY2021 · HL
Imaging the Atherosclerosis Cascade in Sleep Apnea
$846,715Neomi A Shah · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · HL
Immunophenotyping for precision medicine for cardiovascular disease in people living with HIV
$846,562Robert C Kaplan · Albert Einstein College Of Medicine · R01 · FY2019 · HL
Postdoctoral Training in Cardiovascular Disease
$846,245Steven O Marx · Columbia University Health Sciences · T32 · FY2022 · HL
Imaging the Atherosclerosis Cascade in Sleep Apnea
$846,215Neomi A Shah · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · HL
Role of PXR in EDC-induced cardiovascular disease
$846,150Changcheng Zhou · University Of California Riverside · R35 · FY2024 · ES
High Throughput Screen for Amadorase Inhibitors
$845,835Dynamis Therapeutics, Inc. · R44 · FY2004 · DK
COMMUNITY AND COHORT SURVEILLANCE PROGRAMS
$845,583University Of North Carolina Chapel Hill · N01 · FY2000 · HC
Imaging the Atherosclerosis Cascade in Sleep Apnea
$845,286Neomi A Shah · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · HL
Contemporary Classification of Myocardial Injury Events in MESA: Defining Distinct Risk Factor Associations with Myocardial Infarction Type 1-5 and Acute Non-Ischemic Myocardial Injury
$845,239Andrew Defilippis · Vanderbilt University Medical Center · R01 · FY2024 · HL
Extracranial Carotid Atherosclerosis Contributions to Cognitive Impairment and Alzheimer's Disease Risk
$844,972Craig C Weinkauf · University Of Arizona · R01 · FY2021 · AG
Cholesterol reduction and cardiovascular risk in Type 1 diabetes
$844,283Ira Jay Goldberg · New York University School Of Medicine · R01 · FY2025 · HL
Cholesterol reduction and cardiovascular risk in Type 1 diabetes
$844,212Ira Jay Goldberg · New York University School Of Medicine · R01 · FY2024 · HL
Cholesterol reduction and cardiovascular risk in Type 1 diabetes
$844,142Ira Jay Goldberg · New York University School Of Medicine · R01 · FY2023 · HL
Precursors of Stroke Incidence and Prognosis
$844,102Philip A Wolf · Boston University Medical Campus · R01 · FY2011 · NS
Macrophages in homeostasis and cardiovascular disease
$843,878Filip K Swirski · Massachusetts General Hospital · R35 · FY2019 · HL
Macrophages in homeostasis and cardiovascular disease
$843,878Filip K Swirski · Massachusetts General Hospital · R35 · FY2020 · HL
Vascular CT contrast agent development
$843,622Michael A Davis · Nextrast, Inc. · R44 · FY2021 · HL
Ischemic cardiac injury regulates sleep through an immune-mediated heart-brain axis
$843,607Cameron Stuart McAlpine · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · HL
Immunophenotyping for precision medicine for cardiovascular disease in people living with HIV
$843,391Robert C Kaplan · Albert Einstein College Of Medicine · R01 · FY2020 · HL
SPPACE INSTI Study: Sex-specific Predictors, Pathways, And Cardiometabolic Effects of Weight Gain Associated with Integrase Strand-Transfer Inhibitors
$842,314Cecile Delille Lahiri · Emory University · R01 · FY2023 · DK
Characterization And Functional Significance Of P450 Arachidonate Epoxygenases
$842,202Darryl C Zeldin · National Institute Of Environmental Health Sciences · ZIA · FY2017 · ES
IGF::OT::IGF ATHEROSCLEROSIS IN RISK COMMUNITIES - FIELD CENTER - CORE STUDY OPERATIONS
$842,093Josef Coresh · Johns Hopkins University · N01 · FY2021 · HL
Role of innate immunity in HIV related vascular disease: biomarkers & mechanisms
$841,929Robert C Kaplan · Albert Einstein College Of Medicine, Inc · R01 · FY2016 · HL